dan 2163 has been researched along with Hebephrenic Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaiva, G | 1 |
| Thomas, P | 1 |
| Llorca, PM | 1 |
| Dupont, S | 1 |
| Cottencin, O | 1 |
| Devos, P | 1 |
| Mazas, O | 1 |
| Rascle, C | 1 |
| Steinling, M | 1 |
| Goudemand, M | 1 |
| Cassan, P | 1 |
1 trial available for dan 2163 and Hebephrenic Schizophrenia
| Article | Year |
|---|---|
[Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzamides; Clinical Trials as Topic; Double-Blind Method; Humans | 1985 |
1 other study available for dan 2163 and Hebephrenic Schizophrenia
| Article | Year |
|---|---|
SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cerebral Cortex; Dominance, Cerebral; Dose-Response Relati | 2002 |